Page last updated: 2024-11-03

risperidone and Atypical Lipomatous Tumor

risperidone has been researched along with Atypical Lipomatous Tumor in 1 studies

Risperidone: A selective blocker of DOPAMINE D2 RECEPTORS and SEROTONIN 5-HT2 RECEPTORS that acts as an atypical antipsychotic agent. It has been shown to improve both positive and negative symptoms in the treatment of SCHIZOPHRENIA.
risperidone : A member of the class of pyridopyrimidines that is 2-methyl-6,7,8,9-tetrahydropyrido[1,2-a]pyrimidin-4-one carrying an additional 2-[4-(6-fluoro-1,2-benzoxazol-3-yl)piperidin-1-yl]ethyl group at position 2.

Research Excerpts

ExcerptRelevanceReference
" We have appropriated a model whereby heterochromatin is established through 24- or 48-h lipopolysaccharide (LPS) treatment, and tested the epigenetic effects of risperidone along the adenylyl cyclase/protein kinase A (AC/PKA) pathway in human liposarcoma cells that express the LPS-sensitive Toll-like receptor (TLR)-4."3.91Risperidone effects on heterochromatin: the role of kinase signaling. ( Chase, KA; Feiner, B; Melbourne, JK; Rosen, C; Sharma, RP, 2019)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Feiner, B1
Chase, KA1
Melbourne, JK1
Rosen, C1
Sharma, RP1

Other Studies

1 other study available for risperidone and Atypical Lipomatous Tumor

ArticleYear
Risperidone effects on heterochromatin: the role of kinase signaling.
    Clinical and experimental immunology, 2019, Volume: 196, Issue:1

    Topics: Adenylyl Cyclases; Animals; Antipsychotic Agents; Cell Line, Tumor; Chromosomal Proteins, Non-Histon

2019